We determined the effects of phorbol 12,13-dibutyrate (PDB), which activates protein kinase C, on pial arteriolar diameter and cerebrospinal fluid (CSF) prostanoid levels in newborn pigs. A closed cranial window was implanted, and the diameter of one pial arteriole was determined by intravital microscopy. In addition, CSF was sampled from under the window, and prostanoid levels (prostaglandin [PG] E2, 6-keto-PGFI,, PGF2a, and thromboxane B2) were determined by radioimmunoassay. Diameter and CSF prostanoid levels were determined during application of artificial CSF containing no drugs and during application of 10-8, 10-7, and 10-6 M PDB. We also determined effects of 4a-phorbol 12,13-didecanoate (4a.PDD), a phorbol ester that does not activate protein kinase C, and dimethyl sulfoxide, the vehicle for the phorbol esters, on pial arteriolar diameter and CSF prostanoid levels. Initial diameters were 100-200 gm. At 10-8_10-6 M, PDB progressively constricted pial arterioles and increased CSF levels of prostanoids; the other phorbol ester and dimethyl sulfoxide had no such effects. Baseline arteriolar diameter was 147± 17 ,um (mean±SEM), and diameter was 140± 17 ,um at 10`M PDB, 120±18 gm at 10-7 M PDB (p<0.05), and 108± 14 ,um at 10-6 M PDB (p<0.05) (n=5). At 10-6 M PDB, CSF levels of PGE2 increased from 2,030±616 to 13,622±4,228 pg/ml (n=7), PGF2a increased from 3,362± 1,107 to 8,270±1,708 pg/ml (n =6), and 6 -keto-PGF1. increased from 1,637±412 to 3,451±727 pg/ml (n=5). 4o..Phorbol 12,13-didecanoate and dimethyl sulfoxide did not increase prostanoid levels at any dose. Inhibition of prostanoid synthesis by indomethacin pretreatment (5 mg/kg i.v.) (n=5) or topical quinacrine (10-3 M) (n=5) blocked increases in prostanoid production during application of PDB but did not alter arteriolar responses. We conclude that PDB is a potent constrictor of pial arterioles and inducer of prostanoid production by cerebral vessels and/or tissues in piglets. (Circulation Research 1991;69:1253-1258 
PDB, 120±18 gm at 10-7 M PDB (p<0.05), and 108± 14 ,um at 10-6 M PDB (p<0.05) (n=5). At 10-6 M PDB, CSF levels of PGE2 increased from 2,030±616 to 13,622±4,228 pg/ml (n=7), PGF2a increased from 3,362± 1,107 to 8,270±1,708 pg/ml (n =6), and 6 -keto-PGF1. increased from 1,637±412 to 3,451±727 pg/ml (n=5). 4o..Phorbol 12,13-didecanoate and dimethyl sulfoxide did not increase prostanoid levels at any dose. Inhibition of prostanoid synthesis by indomethacin pretreatment (5 mg/kg i.v.) (n=5) or topical quinacrine (10-3 M) (n=5) blocked increases in prostanoid production during application of PDB but did not alter arteriolar responses. We conclude that PDB is a potent constrictor of pial arterioles and inducer of prostanoid production by cerebral vessels and/or tissues in piglets. ( The purpose of this study was to explore effects of phorbol esters on the piglet pial circulation. Several receptor-mediated events that may involve hydrolysis of phosphatidylinositide and activation of protein kinase C, involving neurotransmitters such as norepinephrine and acetylcholine,1920 result in constriction of piglet pial arterioles and increased prostanoid levels in periarachnoid cerebrospinal fluid (CSF).21-24 However, in contrast to increased intracellular calcium levels, it is unknown whether activation of protein kinase C could cause these effects. We tested three hypotheses: 1) Topical application of phorbol esters leads to constriction of pial arterioles. 2) Application of phorbol esters increases production of prostanoids by cerebral vessels and/or tissues. 3) Blockade of prostanoid production augments constriction of cerebral arterioles by phorbol esters.
Materials and Methods Piglets initially were anesthetized with ketamine hydrochloride and acepromazine (33 and 3.3 mg/kg i.m., respectively), followed by a-chloralose (50 mg/kg i.v. initially, followed by 10 mg/kg/hr). Catheters were placed into a femoral artery to record blood pressure and to sample for gases and pH and into a femoral vein for injection of drugs and fluids. The piglets were intubated and ventilated with air. Body temperature was maintained at 37-38°C using a water-circulating rubber heating pad. After the scalp was removed, a hole 2 cm in diameter was made in the skull over the parietal cortex. The dura and arachnoid membranes were cut without touching the brain, and all cut edges were reflected over the bone. A stainless-steel and glass cranial window was placed in the hole and cemented into the skull with dental acrylic. The space under the window was filled, through needles incorporated into the sides of the window, with artificial CSF (aCSF) of the following composition (mM): KCI 2.9, MgCl2 1.4, CaCl2 1.2, NaCl 132, NaHCO3 24.6, urea 6.7, and glucose 3.7. The aCSF was warmed to 39°C and equilibrated with 6.5% CO2 and 6% 02, with the balance N2. When the blood gases and pH were within normal values for each piglet, the cranial window was flushed with aCSF several times at 5-10-minute intervals. One arteriole was selected for study in each piglet.
For baseline determinations of values, a CSF was infused into the window and allowed to remain in place for 10 minutes. At the end of this period, the diameter of the arteriole of interest was determined, and a CSF sample was collected for later assay for prostanoids. We obtained a 300 -,l sample of CSF from under the window by collecting from one port of the cranial window while gently infusing through another port with fresh aCSF. Samples were collected in 5 -ml Sarstedt tubes and immediately placed into a freezer. Samples were kept frozen until assayed. After determination of baseline diameter and collection of a CSF sample, the piglets were divided into separate groups and had aCSF containing one of the following infused under the window: phorbol 12,13-dibutyrate (PDB, Sigma Chemical Co., St. Louis, Mo.) (n=7), 4a-phorbol 12,13-didecanoate and 0.1% at 10`6 M. The phorbol esters or DMSO were allowed to stay under the window for 10 minutes at each dose. Maximal responses for diameter were recorded, and a CSF sample was collected at the end of the 10-minute period. The previous dose was flushed out with the next higher dose.
In two other separate groups of piglets, we examined effects of inhibition of prostanoid synthesis using two different approaches. First, we inhibited prostaglandin endoperoxide synthase by pretreatment with indomethacin trihydrate (5 mg/kg i.v., n =5) (Merck Sharp & Dohme, Rahway, N.J.). Indomethacin was given at least 30 minutes before application of PDB. We have shown previously that this dose of indomethacin given in this way is able to prevent increases in CSF levels of prostanoids to a number of physiological and pharmacological conditions where CSF levels increase or to attenuate increases in CSF prostanoid levels in response to topical application of arachidonic acid.26 27 After indomethacin pretreatment and an appropriate waiting period, we determined pial arteriolar diameter and sampled CSF during baseline conditions and during application of ascending concentrations (10'8, 10-7, and 10-6 M) of PDB. Once again we kept each dose under the window for 10 minutes and flushed out that dose with the next higher one. In a second approach, we inhibited production of prostanoids by coadministration of quinacrine (Sigma), an inhibitor of phospholipase A2.2329 Quinacrine in aCSF (10`3 M) (n=5) was infused under the window for 10 minutes during baseline arteriolar diameter measurement and CSF collection and then coadministered at this concentration for 10 minutes with ascending doses of PDB , and 106 M).
Prostanoid Analysis
The technique for radioimmunoassay of prostanoids in CSF has been described previously.22 Briefly, prostaglandin (PG) E2, 6-keto-PGFia, PGF2a, and thromboxane B2 were analyzed by radioimmunoassay against an aCSF background. Antibodies were produced in rabbits in our laboratory using prostanoids conjugated to thyroglobulin. The assays were carried out in gelatin tris(hydroxymethyl)aminomethane buffer with the appropriate tritiated prostanoids. After incubation at 4°C for 24 hours, the free fraction was separated from that bound to antibody using dextran-coated charcoal. and by 27+2% at 10-6 M ( Table 1 , Figures 1 and  2) . Onset of constriction occurred relatively rapidly (i.e., 1-5 minutes at effective doses). Presented in Figure 1 is a graphical representation from an experiment in which 106 M PDB was infused under the window and pial arteriolar diameter was measured for 60 minutes. Substantial constriction (16%) had already occurred by 1 minute of application and was sustained for at least 60 minutes, despite washing out the PDB at 10 minutes with aCSF. In contrast to _% PDB, neither 4a-PDD nor DMSO decreased arteriolar diameter (Table 1) .
Detectable amounts of prostanoids were present in CSF under baseline conditions ( Table 2 ). The predominant prostanoids during these conditions were PGE2 and PGF2a, followed by 6-keto-PGFI, and then followed by thromboxane B2. PDB application increased CSF levels of PGE2, 6-keto-PGFia, and PGF2, starting at 10 8 M, and thromboxane B2 increased starting at 10-6 M. Maximal responses represent a sevenfold increase from baseline for PGE2 and a slightly greater than twofold increase for the other prostanoids. In contrast, neither 4a-PDD nor DMSO increased CSF levels at any dose given (Table 2) . After blockade of PG endoperoxide synthase with indomethacin, PDB decreased arteriolar diameter at 10`6 M. (Table 1, Figure 2 ). After phospholipase A2 inhibition with quinacrine, PDB decreased arteriolar diameter at 106 M.
We determined CSF PGE2 levels in both the indomethacin and quinacrine groups to assess efficacy of blockade of prostanoid production. PGE2 levels during 10 6 M PDB were attenuated 94% by indomethacin administration (PGE2 value =814 pg/ ml, n=2) and 92% by quinacrine administration (PGE2 value= 1,124 pg/ml, n=2).
When comparing arteriolar diameter during the four conditions (baseline and three doses of PDB) in the no-treatment, indomethacin, and quinacrine groups using a two-dimensional analysis of variance, there was no difference between any of the groups. Maximal responses to PDB for the three groups are shown in Figure 2 .
Discussion
The new findings of the present study are that: 1) PDB is a potent constrictor agent in the piglet pial circulation in vivo, 2) PDB induces increases in prostanoid production by cerebral tissues and/or blood vessels, and 3) inhibition of prostanoid production does not alter arteriolar responses to PDB. Thus, the underlying basis is present to allow speculation that several neurotransmitters, such as norepinephrine and acetylcholine, which have similar effects on cerebral vascular diameter and prostanoid production, may exert their actions in part via receptor-linked phosphotidylinositide hydrolysis, production of diacylglycerol, and protein kinase C activation.
Although various phorbol esters or diacylglycerol have been reported to contract a number of blood vessels in vitro,'6"18 the mechanism of constriction is unclear and may vary according to specific vessels or conditions involved. However, contraction could arise via activation of protein kinase C and subsequent phosphorylation of myosin light chain kinase or of the contractile proteins.4,5 In addition, activation of protein kinase C could lead to inhibition of the endothelium-derived relaxing factor,13'30 originally described by Furchgott and Zawadzki.31 However, it seems unlikely that the latter mechanism is important in the present experiment, since we have shown that endothelium-derived relaxing factor does not appear to be important in control of piglet cerebral hemodynamics.23"24 '32 Receptor-mediated hydrolysis of phosphatidylinositol and subsequent production of inositol 1,4,5-trisphosphate and diacylglycerol can constrict vascular smooth muscle.3-5 There is some evidence that inositol 1,4,5-trisphosphate leads to a fast but unsustained constriction, whereas diacylglycerol leads, after a delay of several minutes, to a sustained constriction.9,33'34 In our experiments, PDB produced immediate constriction that was sustained, despite flushing of the brain surface to remove PDB. The reason for the rapid onset of constriction, in contrast to previous studies in isolated vessels, is unclear, as is the cause of prolonged constriction seen by us as well as by others.916 Phorbol esters are resistant to degradation and thus probably result in prolonged activation of protein kinase C. 3 In addition to causing pial arteriolar constriction, PDB also dramatically increased CSF prostanoid levels. The biggest increase was for PGE2, where levels in CSF increased sevenfold; levels of the other prostanoids more than doubled. The mechanism of production of prostanoids is unclear but could involve several mechanisms, including direct phosphorylation and activation of phospholipase A2, or Since PDB increases CSF levels of prostanoids, it was reasonable to assume that blockade of prostanoid production would enhance constriction. In the piglet pial circulation, PGE2 and prostacyclin are dilator stimuli, whereas thromboxane and PGE2a are constrictor agents.21"40'4' Further, during baseline conditions and the presence of PDB, levels for PGE2, PGF2a, and prostacyclin are within the vasoactive range.21'40'4' However, neither indomethacin nor quinacrine treatment changed the pattern of response to PDB. It is possible that production of dilator and constriction prostanoids was such that equal amounts of each group were produced and the net vasoactive effect was one of no net change. This possibility is unlikely since topical application of arachidonic acid, which should produce the same distribution of dilator and constrictor prostanoids, causes pial arteriolar dilation. 22 Another possibility is that the vascular effects of PDB were so strong and direct that prostanoids were unable to counteract them.
Activation of protein kinase C by PDB results in pial arteriolar constriction and increased synthesis of prostanoids by cerebral vessels and/or tissues -effects that are similar to those we see after activation of noradrenergic and muscarinic receptors by exogenous neurotransmitters.2122 Since these and other receptors are coupled to phospholipase C, it is tempting to suggest that effects of norepinephrine and acetylcholine are mediated in whole or in part by activation of protein kinase C.
Receptors for neurotransmitters can be coupled directly to phospholipase A2 and cause production of prostanoids. However, it appears that, once second messengers such as cAMP, cGMP, and diacylglycerol are formed in the piglet parietal cortex, only one kind can proceed to activate phospholipase A2-namely, diacylglycerol through activation of protein kinase C. In previous studies in which we activated adenylate cyclase with isoproterenol21 and guanylate cyclase with arginine-containing compounds,32 no augmented production of prostanoids occurred (Reference 21 and authors' unpublished observations).
In conclusion, the phorbol ester PDB is a potent constrictor agent and stimulus to prostanoid production in the in vivo cerebral circulation of the newborn pig. Our results provide evidence that protein kinase C could participate in regulation of cerebrovascular tone and cerebral prostanoid production.
